Chugai Pharmabody Research
Sotaro Naoi is a Principal Scientist at Chugai Pharmabody Research since September 2022, having previously served as a Translational PKPD Research Scientist at Chugai Pharmaceutical Co., Ltd. from April 2015 to September 2022. Sotaro Naoi holds a Ph.D. in Pharmaceutical Sciences from The University of Tokyo.
This person is not in any offices
Chugai Pharmabody Research
1 followers
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.